WELLGISTICS HEALTH INC
WGRXNASDAQTrading Snapshot
- Day Range
- $3.51 β $3.54
- 52-Week Range
- $2.49 β $97.50
- Volume
- $1.69B
- Avg Volume
- $1.55B
- Shares Outstanding
- 2.5M
- Next Earnings
- Nov 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $23M
- Last Q Revenue
- $2M
- P/E Ratio
- -0.1
- P/S Ratio
- 1.1x
- EPS (TTM)
- $-34.29
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +36.7%
Why Investors Own WGRX
- βHigh-growth profile β revenue up +14.2% YoY with expanding US Equity exposure.
- βHealthy economics β 64% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
WELLGISTICS HEALTH INC
WGRXAbout WELLGISTICS HEALTH INC
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
WELLGISTICS HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift WGRX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
WELLGISTICS HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.